Loading...
XJPX
3151
Market cap399mUSD
Dec 05, Last price  
1,283.00JPY
1D
-0.62%
1Q
-0.85%
Jan 2017
29.60%
IPO
143.92%
Name

Vital Ksk Holdings Inc

Chart & Performance

D1W1MN
XJPX:3151 chart
P/E
8.49
P/S
0.10
EPS
151.11
Div Yield, %
3.43%
Shrs. gr., 5y
-5.42%
Rev. gr., 5y
1.31%
Revenues
600.37b
+2.19%
534,698,000,000532,053,000,000541,636,000,000547,590,000,000564,645,000,000548,007,000,000620,978,000,000581,117,000,000565,587,000,000559,718,000,000562,529,000,000537,058,000,000577,249,000,000579,772,000,000587,481,000,000600,370,000,000
Net income
7.31b
+25.09%
2,786,000,000-1,067,000,0003,154,000,0003,908,000,0004,235,000,0004,527,000,0006,556,000,0004,778,000,0004,467,000,0005,084,000,0004,642,000,0001,171,000,0004,770,000,0004,831,000,0005,843,000,0007,309,000,000
CFO
-8.02b
L
3,005,000,0005,226,000,00012,863,000,00010,123,000,000-10,409,000,0009,515,000,000-2,350,000,0001,116,000,00016,783,000,00018,229,000,000-8,323,000,000-1,389,000,0007,487,000,000-3,001,000,00023,570,000,000-8,024,000,000
Dividend
Mar 30, 202634 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
URL
https://www.vitalksk.co.jp/
IPO date
Apr 01, 2009
Employees
3,719
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT